Neoadjuvant Chemotherapy for Oropharyngeal Cancer Treatment De-Escalation: From Historical Failures to Contemporary HPV-Driven Paradigms
Alvaro Sanabria, Juan P. Rodrigo, Anna Luíza Damaceno Araújo, Luiz P. Kowalski · 2025
Read Neoadjuvant Chemotherapy for Oropharyngeal Cancer Treatment De-Escalation: From Historical Failures to Contemporary HPV-Driven Paradigms by Alvaro Sanabria, Juan P. Rodrigo, Anna Luíza Damaceno Araújo, Luiz P. Kowalski (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12784758.txt.
Description
Alvaro Sanabria and three co-authors review chemotherapy given before main treatment for throat cancer at the back of the mouth, in this 2025 paper. Cancers of this type driven by the HPV virus respond well to treatment, so doctors hope lighter regimens can spare patients harsh side effects. Early chemotherapy might shrink tumors enough to allow that lighter path.
Older studies, run before HPV testing was routine, showed mixed responses and no survival gain. Newer series in HPV positive patients report strong tumor shrinkage and high survival after early chemotherapy plus surgery or reduced chemoradiation. Patients also needed feeding tubes less often and swallowed better. The authors caution that these series are small and not randomized, so the approach stays promising rather than proven.
Catalog record
| CREATOR | Alvaro Sanabria, Juan P. Rodrigo, Anna Luíza Damaceno Araújo, Luiz P. Kowalski |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |